• Nenhum resultado encontrado

[PDF] Top 20 Methylome of breast cancer molecular subtypes: diagnosis and prognosis biomarkers

Has 10000 "Methylome of breast cancer molecular subtypes: diagnosis and prognosis biomarkers" found on our website. Below are the top 20 most common "Methylome of breast cancer molecular subtypes: diagnosis and prognosis biomarkers".

Methylome of breast cancer molecular subtypes: diagnosis and prognosis biomarkers

Methylome of breast cancer molecular subtypes: diagnosis and prognosis biomarkers

... Age-Standardized Breast Cancer Incidence Worlwide in ...number of cancer cases for both sexes in Europe in 2012 ...Incidence and Mortality Rates (per 100 000) in Portugal in 2012 ... See full document

75

The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.

The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.

... because of its high cost and high technological and clinical expertise ...panel of immunohistochemical markers including ER, PR, HER-2, cytokertain5/6 (CK5/6) and Epidermal Growth ... See full document

13

Studying the value of prognostic and predictive biomarkers in breast cancer pathology

Studying the value of prognostic and predictive biomarkers in breast cancer pathology

... study of stromal TILs and PDL1 expression, the aim was to assess the clinical impact of the expression of these biomarkers in breast cancer, namely their correlation with ... See full document

249

Biomarkers for diagnosis and surveillance of patients with  bladder cancer: a comprehensive review

Biomarkers for diagnosis and surveillance of patients with  bladder cancer: a comprehensive review

... majority of BC arises from epithelial cells and approximately 90% are urothelial tumors, with squamous and glandular-type tumors as less frequent histologic subtypes; more rarely, bladder ... See full document

29

Volatomic pattern of breast cancer and cancer-free tissues as a powerful strategy to identify potential biomarkers

Volatomic pattern of breast cancer and cancer-free tissues as a powerful strategy to identify potential biomarkers

... complex and time-consuming analysis is required that uses many di fferent assays, such as the deter- mination of histological type and grading and the evaluation of estrogen receptor ... See full document

10

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

... screening, diagnosis, and treatment, colorectal cancer (CRC) is the third most common cancer and the fourth-leading cause of cancer death worldwide ...10%–20% of ... See full document

13

Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers

Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers

... advent of high-throughput technolo- gies, gene expression profiling has enabled a more com- prehensive view of the molecular identity of breast ...major molecular and ... See full document

12

Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers: a powerful strategy for breast cancer diagnosis

Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers: a powerful strategy for breast cancer diagnosis

... specific and sensitive biomarkers for precise and accurate screen- ing, diagnosis, prognosis and monitoring of high risk cancer to aid therapeutic decisions ... See full document

9

Association of MMP8 gene variation with breast cancer prognosis

Association of MMP8 gene variation with breast cancer prognosis

... Breast Cancer Res 2008, 10(Suppl 2):P65 (doi: ...Background Cancer Research UK (2007) [1] stated that the most common cancer for women in the United Kingdom is breast ...20% of ... See full document

49

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

... status of lymph nodes, histological types of the tumor, pathological grade, and hormone receptor ...more biomarkers are needed for therapy and prediction of outcome because human ... See full document

17

Metastatic breast cancer: finding molecular biomarkers in liquid biopsies

Metastatic breast cancer: finding molecular biomarkers in liquid biopsies

... women and a major cause of morbidity and mortality ...BrCa diagnosis and prognosis assessment, patients with similar clinicopathological features often show different clinical ... See full document

86

Circulating cell-free DNA as a biomarker in the diagnosis and prognosis of colorectal cancer

Circulating cell-free DNA as a biomarker in the diagnosis and prognosis of colorectal cancer

... Molecular biomarkers in blood samples are proposed for diagnosis and prognosis of the CRC, such as circulating free DNA (ccfDNA) (Yörüker et ...mechanisms of the apoptosis ... See full document

14

miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study.

miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study.

... with breast cancer at a younger age, which has been reported to be associated with adverse pathological features such as histological high grade, negative hormone receptors, HER2 overexpression and ... See full document

8

Automatic Detection of Anatomical Structures and Breast Cancer Diagnosis on X-Ray Mammography

Automatic Detection of Anatomical Structures and Breast Cancer Diagnosis on X-Ray Mammography

... terms of the work, according to the past chapters, it can be divided into different phases, including: (1) pre-processing, (2) detection of suspicious regions and characterization (3) feature ... See full document

184

External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.

External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.

... invasive breast carcinoma that was less than 5 cm in diameter at pathological examination (pT1 or pT2); without involvement of the apical axillary lymph nodes; the age at diagnosis was 52 years or ... See full document

10

Diagnosis, Prognosis and Personalized Treatment of Cystic Fibrosis

Diagnosis, Prognosis and Personalized Treatment of Cystic Fibrosis

... supportive of my struggle, for all the reality checks, for sharing your experience with me and for saving me a position in your future lab (I will not forget ...advices and suggestions and for ... See full document

90

Biomarkers research for diagnosis and prognosis of rejections of renal allograft in human transplant by fourier transform infrared spectroscopy

Biomarkers research for diagnosis and prognosis of rejections of renal allograft in human transplant by fourier transform infrared spectroscopy

... patience and help with my first steps in FTIR; Helder da Paz, that always continued with his contagious positive spirit and kept on singing even throughout the darkest moments; to Filipa Pires, the answer ... See full document

26

Model Comparison for Breast Cancer Prognosis Based on Clinical Data.

Model Comparison for Breast Cancer Prognosis Based on Clinical Data.

... period of time. For example, a 5-year prognosis of 80% would mean that the chance of surviving 5 years after cancer diagnosis, or surgery, is estimated as a 80% ...prediction ... See full document

15

Microwave Imaging of the Axilla to Aid Breast Cancer Diagnosis

Microwave Imaging of the Axilla to Aid Breast Cancer Diagnosis

... removed and is an important step prior to the focusing algorithm and image ...algorithms and observed that, although both Rotation Subtraction and Average Subtraction algorithms are ... See full document

102

Meningioma and Breast Cancer: Survival of Patients with Synchronous and Metachronous Meningioma and Breast Cancer

Meningioma and Breast Cancer: Survival of Patients with Synchronous and Metachronous Meningioma and Breast Cancer

... survival of the biology and histology of meningioma and breast cancer in each ...stratification of the study sample according to meningioma grade revealed no influ- ence ... See full document

9

Show all 10000 documents...